PortfoliosLab logoPortfoliosLab logo
RDNT vs. DGX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

RDNT vs. DGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RadNet, Inc. (RDNT) and Quest Diagnostics Incorporated (DGX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

RDNT vs. DGX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
RDNT
RadNet, Inc.
-22.48%2.16%100.86%84.65%-37.46%53.86%-3.60%99.61%0.69%56.59%
DGX
Quest Diagnostics Incorporated
14.44%17.20%11.77%-10.05%-7.80%47.86%14.11%31.13%-13.84%9.16%

Fundamentals

Market Cap

RDNT:

$4.16B

DGX:

$22.14B

EPS

RDNT:

$0.63

DGX:

$8.80

PE Ratio

RDNT:

88.28

DGX:

22.45

PS Ratio

RDNT:

2.02

DGX:

2.02

PB Ratio

RDNT:

3.82

DGX:

3.09

Total Revenue (TTM)

RDNT:

$2.04B

DGX:

$11.04B

Gross Profit (TTM)

RDNT:

$228.54M

DGX:

$3.67B

EBITDA (TTM)

RDNT:

$253.95M

DGX:

$2.02B

Returns By Period

In the year-to-date period, RDNT achieves a -22.48% return, which is significantly lower than DGX's 14.44% return. Over the past 10 years, RDNT has outperformed DGX with an annualized return of 27.48%, while DGX has yielded a comparatively lower 12.77% annualized return.


RDNT

1D
-1.04%
1M
-26.47%
YTD
-22.48%
6M
-29.08%
1Y
9.27%
3Y*
30.25%
5Y*
20.23%
10Y*
27.48%

DGX

1D
0.87%
1M
-5.97%
YTD
14.44%
6M
9.56%
1Y
18.95%
3Y*
14.07%
5Y*
11.00%
10Y*
12.77%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

RDNT vs. DGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RDNT
RDNT Risk / Return Rank: 4747
Overall Rank
RDNT Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
RDNT Sortino Ratio Rank: 4545
Sortino Ratio Rank
RDNT Omega Ratio Rank: 4242
Omega Ratio Rank
RDNT Calmar Ratio Rank: 4848
Calmar Ratio Rank
RDNT Martin Ratio Rank: 5151
Martin Ratio Rank

DGX
DGX Risk / Return Rank: 6969
Overall Rank
DGX Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
DGX Sortino Ratio Rank: 6464
Sortino Ratio Rank
DGX Omega Ratio Rank: 6161
Omega Ratio Rank
DGX Calmar Ratio Rank: 7575
Calmar Ratio Rank
DGX Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RDNT vs. DGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for RadNet, Inc. (RDNT) and Quest Diagnostics Incorporated (DGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RDNTDGXDifference

Sharpe ratio

Return per unit of total volatility

0.21

0.81

-0.60

Sortino ratio

Return per unit of downside risk

0.66

1.38

-0.72

Omega ratio

Gain probability vs. loss probability

1.08

1.17

-0.09

Calmar ratio

Return relative to maximum drawdown

0.33

1.94

-1.61

Martin ratio

Return relative to average drawdown

0.96

4.31

-3.35

RDNT vs. DGX - Sharpe Ratio Comparison

The current RDNT Sharpe Ratio is 0.21, which is lower than the DGX Sharpe Ratio of 0.81. The chart below compares the historical Sharpe Ratios of RDNT and DGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


RDNTDGXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.21

0.81

-0.60

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.45

0.51

-0.06

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.57

0.54

+0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.19

0.53

-0.35

Correlation

The correlation between RDNT and DGX is 0.14, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

RDNT vs. DGX - Dividend Comparison

RDNT has not paid dividends to shareholders, while DGX's dividend yield for the trailing twelve months is around 1.62%.


TTM20252024202320222021202020192018201720162015
RDNT
RadNet, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
DGX
Quest Diagnostics Incorporated
1.62%1.82%1.96%2.02%1.66%1.40%1.85%1.99%2.34%1.83%1.72%2.07%

Drawdowns

RDNT vs. DGX - Drawdown Comparison

The maximum RDNT drawdown since its inception was -92.15%, which is greater than DGX's maximum drawdown of -49.46%. Use the drawdown chart below to compare losses from any high point for RDNT and DGX.


Loading graphics...

Drawdown Indicators


RDNTDGXDifference

Max Drawdown

Largest peak-to-trough decline

-92.15%

-49.46%

-42.69%

Max Drawdown (1Y)

Largest decline over 1 year

-34.53%

-9.81%

-24.72%

Max Drawdown (5Y)

Largest decline over 5 years

-60.24%

-28.62%

-31.62%

Max Drawdown (10Y)

Largest decline over 10 years

-73.43%

-36.60%

-36.83%

Current Drawdown

Current decline from peak

-35.97%

-6.71%

-29.26%

Average Drawdown

Average peak-to-trough decline

-44.13%

-11.92%

-32.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

11.76%

4.41%

+7.35%

Volatility

RDNT vs. DGX - Volatility Comparison

RadNet, Inc. (RDNT) has a higher volatility of 14.73% compared to Quest Diagnostics Incorporated (DGX) at 4.48%. This indicates that RDNT's price experiences larger fluctuations and is considered to be riskier than DGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


RDNTDGXDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.73%

4.48%

+10.25%

Volatility (6M)

Calculated over the trailing 6-month period

31.38%

16.61%

+14.77%

Volatility (1Y)

Calculated over the trailing 1-year period

44.79%

23.52%

+21.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.94%

21.65%

+23.29%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

48.19%

23.63%

+24.56%

Financials

RDNT vs. DGX - Financials Comparison

This section allows you to compare key financial metrics between RadNet, Inc. and Quest Diagnostics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


500.00M1.00B1.50B2.00B2.50B3.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
547.71M
2.81B
(RDNT) Total Revenue
(DGX) Total Revenue
Values in USD except per share items

RDNT vs. DGX - Profitability Comparison

The chart below illustrates the profitability comparison between RadNet, Inc. and Quest Diagnostics Incorporated over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

0.0%10.0%20.0%30.0%40.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
12.6%
32.4%
Portfolio components
RDNT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, RadNet, Inc. reported a gross profit of 68.99M and revenue of 547.71M. Therefore, the gross margin over that period was 12.6%.

DGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported a gross profit of 910.00M and revenue of 2.81B. Therefore, the gross margin over that period was 32.4%.

RDNT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, RadNet, Inc. reported an operating income of 27.83M and revenue of 547.71M, resulting in an operating margin of 5.1%.

DGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported an operating income of 386.00M and revenue of 2.81B, resulting in an operating margin of 13.8%.

RDNT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, RadNet, Inc. reported a net income of 64.83M and revenue of 547.71M, resulting in a net margin of 11.8%.

DGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Quest Diagnostics Incorporated reported a net income of 245.00M and revenue of 2.81B, resulting in a net margin of 8.7%.